* Q3 loss per share C$0.05
* Q3 rev C$8.5 mln vs C$15.6 mln (Follows alerts)
May 11 (Reuters) - Canadian biopharmaceutical company Bioniche Life Sciences Inc posted a quarterly loss, hurt by a drop in licensing revenue.
For the third quarter, the company reported a loss of C$4.5 million, or 5 Canadian cents a share, compared with net income of C$4.4 million, or 6 Canadian cents a share, a year earlier.
Total revenue fell 45.5 percent to C$8.5 million and licensing revenue fell to C$0.4 million , compared with C$8.7 million, a year ago.
Analysts on average expected the company to post a loss of 3 Canadian cents a share, according to Thomson Reuters I/B/E/S.
Shares of Ontario-based Bioniche closed at C$1.06 on Wednesday on the Toronto Stock Exchange. (Reporting by Maneesha Tiwari in Bangalore; Editing by Prem Udayabhanu)